Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

Geahča maid

• Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation
  Dahkki: Marcos de Lima, et al.
  Almmustuhtton: (2004)
• Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation
  Dahkki: Raymond Wong, et al.
  Almmustuhtton: (2005)
• A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease
  Dahkki: Couriel, Daniel R., et al.
  Almmustuhtton: (2009)
• Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival
  Dahkki: Issa F. Khouri, et al.
  Almmustuhtton: (2004)
• A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease
  Dahkki: Daniel R. Couriel, et al.
  Almmustuhtton: (2009)